Skip to main content
Contact Us
Subscribe
E-Edition
39°
Site search
Search
Menu
Open user controls
Log In Using Your Account
Log In
Don't have an account?
Sign Up Today
My Account
Dashboard
Profile
Saved items
Logout
Home
About Us
Contact Us
Advertise
Terms and Conditions
Privacy Policy
Home Delivery
Subscription Services
Place an Ad
Promote Your Event
Local Weather
News
Sports
Obits
Multimedia
Photo Galleries
Videos
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Subscribe
Archives
Best of 2025
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
scPharmaceuticals Inc. - Common Stock
(NQ:
SCPH
)
3.680
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 14, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
299,226
Open
3.700
Bid (Size)
3.650 (1)
Ask (Size)
3.860 (16)
Prev. Close
3.680
Today's Range
3.590 - 3.755
52wk Range
3.075 - 6.540
Shares Outstanding
35,769,073
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
12 Health Care Stocks Moving In Friday's Pre-Market Session
April 05, 2024
Via
Benzinga
Earnings Scheduled For March 13, 2024
March 13, 2024
Companies Reporting Before The Bell • Sangamo Therapeutics (NASDAQ:SGMO) is likely to report quarterly loss at $0.26 per share on revenue of $8.10 million.
Via
Benzinga
Performance
YTD
+3.08%
+3.08%
1 Month
+7.60%
+7.60%
3 Month
+9.85%
+9.85%
6 Month
-28.05%
-28.05%
1 Year
-35.89%
-35.89%
More News
Read More
A Preview Of scPharmaceuticals's Earnings
March 12, 2024
Via
Benzinga
Recap: scPharmaceuticals Q3 Earnings
November 08, 2023
Via
Benzinga
Earnings Preview: scPharmaceuticals
November 07, 2023
Via
Benzinga
Earnings Outlook For scPharmaceuticals
August 09, 2023
Via
Benzinga
Earnings Scheduled For November 13, 2024
November 13, 2024
Via
Benzinga
scPharmaceuticals's Earnings Outlook
November 12, 2024
Via
Benzinga
SCPH Stock Earnings: scPharmaceuticals Misses EPS, Misses Revenue for Q2 2024
August 14, 2024
Via
InvestorPlace
Heart Failure-Focused scPharmaceuticals Secures FDA Approval For Expanded Use Of Furoscix, Receives Funding To Expand Commercialization
August 12, 2024
Via
Benzinga
Exposures
Product Safety
7 Short-Squeeze Stocks That Could Beat Down the Bears
July 15, 2024
Via
InvestorPlace
SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024
May 14, 2024
Via
InvestorPlace
Recap: scPharmaceuticals Q4 Earnings
March 13, 2024
Via
Benzinga
The Latest Analyst Ratings for scPharmaceuticals
July 19, 2023
Via
Benzinga
Analyst Ratings for scPharmaceuticals
June 08, 2023
Via
Benzinga
Earnings Outlook For scPharmaceuticals
May 09, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
January 22, 2024
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 7, 2023
September 07, 2023
Via
Benzinga
Earnings Preview For scPharmaceuticals
March 21, 2023
Via
Benzinga
Earnings Scheduled For August 10, 2023
August 10, 2023
Via
Benzinga
Dow Up 150 Points; Gold Jumps Over 2%
March 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
March 23, 2023
Via
Benzinga
Nasdaq Surges Over 2%; Accenture To Reduce 19,000 Jobs
March 23, 2023
Via
Benzinga
KB Home, Accenture, Netflix And Other Big Stocks Moving Higher On Thursday
March 23, 2023
Via
Benzinga
Why Block Shares Are Trading Lower By Over 13%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 23, 2023
Via
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
